As misregulation of the ASPP proteins is responsible for many cancerous transformations, understanding the molecular basis for the opposite activity of the ASPP proteins will provide the basis for developing future anti-cancer lead compounds that inhibit iASPP or mimic the apoptotic activity of ASPP2. The gene discussed is TP53BP2; the disease is cancer.